William Charles Bertrand - Chief Operating Officer at Adaptimmune Therapeutics PLC

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Issuer Symbol
ADAPY on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by William Charles Bertrand since 09 Mar 2025

Holdings reported by William Charles Bertrand for Adaptimmune Therapeutics PLC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares with a nominal value of GBP0.001 per share 986,352 $98,635 $0.1000 28 Aug 2025 Direct
American Depositary Shares representing Ordinary Shares 7,510 $4,362 $0.5808 17 Jan 2025 Direct
Option to purchase Ordinary Shares 1,074,696 20 Feb 2025 Direct Ordinary Shares

Transactions reported by William Charles Bertrand for Adaptimmune Therapeutics PLC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.